Qingdao Kingking Applied Chemistry Co., Ltd. (SHE:002094)
China · Delayed Price · Currency is CNY 4.940
-0.110 (-2.18%)
Sep 30, 2026, 3:04 PM CST
SHE:002094 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,687 | 1,678 | 1,788 | 2,504 | 2,922 | 3,118 |
Other Revenue | 3.03 | 3.1 | 4.63 | 5.17 | 29.69 | 34.79 |
| 1,690 | 1,681 | 1,793 | 2,509 | 2,951 | 3,153 | |
Revenue Growth | -7.07% | -6.25% | -28.55% | -14.99% | -6.40% | -21.21% |
Cost of Revenue | 1,386 | 1,377 | 1,457 | 2,267 | 2,736 | 2,735 |
Gross Profit | 303.97 | 303.51 | 335.86 | 242.13 | 215.39 | 418.28 |
Selling, General & Admin | 174.35 | 183.3 | 201.4 | 193.51 | 324.33 | 411.62 |
Research & Development | 39.58 | 37.28 | 43.17 | 34.23 | 37.06 | 39.29 |
Other Operating Expenses | 9.22 | 10.23 | 11.3 | 10.96 | 10.52 | 9.04 |
Operating Expenses | 226.94 | 235.67 | 258.56 | 238.28 | 428.39 | 495.74 |
Operating Income | 77.03 | 67.84 | 77.3 | 3.84 | -213 | -77.46 |
Interest Expense | -51.49 | -50.34 | -52.97 | -54.13 | -45.62 | -50.98 |
Interest & Investment Income | 51.75 | 75.41 | 74.71 | 125.33 | 6.23 | 125.68 |
Currency Exchange Gain (Loss) | -14.41 | - | - | - | - | - |
Other Non Operating Income (Expenses) | -32.37 | -31.53 | -2.42 | -65.73 | -226.64 | 0.43 |
EBT Excluding Unusual Items | 30.51 | 61.38 | 96.62 | 9.31 | -479.03 | -2.32 |
Impairment of Goodwill | -9.61 | -9.61 | -33.02 | -11.26 | -69.52 | - |
Gain (Loss) on Sale of Investments | -25.97 | -25.97 | -2.54 | 11.57 | -304.97 | -4.7 |
Gain (Loss) on Sale of Assets | 4.42 | -0.04 | 0.02 | 0.18 | -3.51 | -0.06 |
Asset Writedown | -0.63 | -0.16 | -20.18 | -0.79 | -2.01 | -4.07 |
Other Unusual Items | 3.97 | 4.1 | 5.99 | 16.38 | 1.73 | 7.19 |
Pretax Income | 2.69 | 29.7 | 46.9 | 25.4 | -857.31 | -3.97 |
Income Tax Expense | 10.84 | 10.63 | 13.47 | 16.42 | 18.21 | 13.62 |
Earnings From Continuing Operations | -8.15 | 19.07 | 33.43 | 8.98 | -875.51 | -17.59 |
Minority Interest in Earnings | -5.83 | 2.12 | 1.69 | 1.45 | 66.36 | 33.93 |
Net Income | -13.98 | 21.19 | 35.12 | 10.42 | -809.15 | 16.34 |
Net Income to Common | -13.98 | 21.19 | 35.12 | 10.42 | -809.15 | 16.34 |
Net Income Growth | - | -39.66% | 236.91% | - | - | - |
Shares Outstanding (Basic) | 690 | 690 | 691 | 521 | 692 | 817 |
Shares Outstanding (Diluted) | 690 | 690 | 691 | 521 | 692 | 817 |
Shares Change | -0.43% | -0.15% | 32.64% | -24.65% | -15.36% | 18.16% |
EPS (Basic) | -0.02 | 0.03 | 0.05 | 0.02 | -1.17 | 0.02 |
EPS (Diluted) | -0.02 | 0.03 | 0.05 | 0.02 | -1.17 | 0.02 |
EPS Growth | - | -39.57% | 154.00% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -160.74 | -67.92 | -44.96 | 49.35 | 14.66 | -486.71 |
Free Cash Flow Per Share | -0.23 | -0.10 | -0.07 | 0.10 | 0.02 | -0.60 |
Gross Margin | 17.98% | 18.06% | 18.73% | 9.65% | 7.30% | 13.27% |
Operating Margin | 4.56% | 4.04% | 4.31% | 0.15% | -7.22% | -2.46% |
Profit Margin | -0.83% | 1.26% | 1.96% | 0.41% | -27.42% | 0.52% |
Free Cash Flow Margin | -9.51% | -4.04% | -2.51% | 1.97% | 0.50% | -15.44% |
EBITDA | 106.69 | 97.53 | 119.54 | 49.71 | -174.49 | -23.14 |
EBITDA Margin | 6.31% | 5.80% | 6.67% | 1.98% | -5.91% | -0.73% |
D&A For EBITDA | 29.66 | 29.69 | 42.24 | 45.87 | 38.51 | 54.31 |
EBIT | 77.03 | 67.84 | 77.3 | 3.84 | -213 | -77.46 |
EBIT Margin | 4.56% | 4.04% | 4.31% | 0.15% | -7.22% | -2.46% |
Effective Tax Rate | 403.20% | 35.79% | 28.72% | 64.66% | - | - |
Revenue as Reported | 1,690 | 1,681 | 1,793 | - | 2,951 | 3,153 |
Advertising Expenses | - | 13.23 | 16.2 | 19.07 | 17.85 | 41.39 |